• The 5 Pillars of Excellence in Stable Cell Line Development
    Antibody production

    The 5 Pillars of Excellence in Stable Cell Line Development

    Oumayma Rouis Oumayma Rouis 9 min read

    In the rapidly evolving biopharmaceutical industry, stable cell line development (CLD) is the cornerstone of successful therapeutic protein production. Researchers and biomanufacturers alike seek high-quality, stable cell lines that provide…

  1. CAR-T cell therapy

    From the first to the fifth generation of CAR-T cells

    Read more
  2. Others

    Key events of 2025: Meet us to discuss innovation!

    Read more
  3. CAR-T cell therapy

    The structure of CAR-T cells

    Read more
  4. Antibody production

    What are chimeric antibodies?

    Read more
  5. Antibody-drug conjugates

    ADC payloads

    Read more

Let’s talk about science – Scientists in the spotlight

Dr. Louisa James

“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”

Read more
Queen Mary University of London (QMUL, UK) Queen Mary University of London (QMUL, UK)
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Dr. Mara Freire

Reinventing IgY biotherapeutics

Read more
CICECO, University of Aveiro CICECO, University of Aveiro
Reinventing IgY biotherapeutics
Dr. Melanie Conrad

How the environment shapes immune system development during pregnancy

Read more
Charité Medical University in Berlin Charité Medical University in Berlin
How the environment shapes immune system development during pregnancy
Dr. Mohamed Alfaleh

“Cell-based phage display is helping us isolate more biologically relevant antibodies”

Read more
King Abdulaziz University King Abdulaziz University
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Prof. Tomáš Kalina

“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”

Read more
Charles University in Prague Charles University in Prague
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Prof. Richard Pleass

“Antibodies will make a significant contribution to design effective control strategies for COVID-19”

Read more
LSTM LSTM
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
Professor Istvan Toth

“Simplicity is the key to successful large-scale applications”

Read more
Queensland University, Australia Queensland University, Australia
“Simplicity is the key to successful large-scale applications”
See More

Read by topic